Safety and efficacy data on the investigational subcutaneous formulation of ORENCIA in adults with moderate to severe rheumatoid arthritis to be presented at the American College of Rheumatology ...
(NAPSI)ORENCIA (abatacept) is the first and only biologic for the treatment of adults with moderate to severe rheumatoid arthritis (RA) available in both self-injectable (under the skin) and ...
Bristol-Myers Squibb Company (NYSE: BMY) today announced the results of year two data from AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naïve rheumatoid arthritis (RA) Subjects With ...
Bristol-Myers Squibb has presented two-year data from a head-to-head study which show that its rheumatoid arthritis drug Orencia has comparable safety and efficacy to AbbVie's blockbuster Humira.
NEW YORK Patients with rheumatoid arthritis derive about as much benefit from a weekly injection of a biotech drug made by Bristol-Myers Squibb for the disease as they do from receiving it via IV on a ...
August 2, 2011 — The US Food and Drug Administration (FDA) has approved a subcutaneous formulation of abatacept (Orencia, Bristol-Myers Squibb Co) for the treatment of adults with moderate-to-severe ...
Please provide your email address to receive an email when new articles are posted on . Bristol-Myers Squibb Company announced Orencia intravenous infusion and subcutaneous injection in combination ...
Efficacy and Safety Data Further Supporting Use of ORENCIA in New-to-Biologic Patients with Moderate to Severe Rheumatoid Arthritis Added to Product Labeling NEW YORK--(BUSINESS WIRE)--Bristol-Myers ...
Dec. 29, 2005 — The U.S. Food and Drug Administration (FDA) has approved abatacept injection for the treatment of moderately to severely active rheumatoid arthritis in adults who have had an ...
The approval of the prefilled syringe was based on dosing, efficacy, and safety data of SC abatacept in JIA among patients aged 2-17 years with inadequate response to at least one nonbiologic or ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Patient-reported outcomes were similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback